Will single-time tumor profiling and a "guilt by association" approach allow us to outsmart HER2-positive breast cancer?
- PMID: 17317812
- DOI: 10.1158/1078-0432.CCR-06-2717
Will single-time tumor profiling and a "guilt by association" approach allow us to outsmart HER2-positive breast cancer?
Comment on
-
Predictors of resistance to preoperative trastuzumab and vinorelbine for HER2-positive early breast cancer.Clin Cancer Res. 2007 Feb 15;13(4):1198-207. doi: 10.1158/1078-0432.CCR-06-1304. Clin Cancer Res. 2007. PMID: 17317830 Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
